| (Values in U.S. Thousands) | Dec, 2020 | Sep, 2020 | Jun, 2020 | Mar, 2020 | Dec, 2019 |
| Sales | -360 | 0 | 0 | 360 | 80 |
| Sales Growth | unch | unch | -100.00% | +350.00% | -80.95% |
| Net Income | -3,290 | -7,130 | -3,630 | -3,540 | -1,340 |
| Net Income Growth | +53.86% | -96.42% | -2.54% | -164.18% | -59.52% |
Akers Biosciences (AKER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.